LeadStory

CBC News

WHO backs GLP-1 meds like Ozempic to treat obesity

CBC News · Just In
CBC News
CBC News
Just In

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability. Brands such as Ozempic and Wegovy are already wildly popular in North America.

Breakdown
  • WHO now recommends GLP-1 drugs like Ozempic for obesity treatment 9s
  • Over 1 billion people globally are considered obese 22s
  • GLP-1 drugs often not covered for obesity; average cost is $500/month in Canada 53s
  • Experts warn GLP-1 drugs are not a quick fix and have potential side effects 1m 23s
  • WHO says less than 10% of eligible patients may access GLP-1 drugs by 2030 1m 39s